Use of composite endpoints in early and intermediate age-related macular degeneration clinical trials – state-of-the-art and future directions
Terheyden J.H. Schmitz-Valckenberg S. Crabb D. Dunbar H. Luhmann U. Behning C. Schmid M. Pires I. Cunha-Vaz J. Tufail A. Weissgerber G. Leal S. Holz F.G. Finger R.P.
Ophthalmologica. 2020 Dec 7. doi: 10.1159/000513591.